WASOG2026

Accepted Abstracts

Aproved

ID Code Title
1759 PO35 Challenges in diagnosis and managment in endobronchial sarcoidosis

Brenda Varela; Castaño, Gonzalo; Claus, Murilo; Rolleri, Juan Carlos

2731 PO61 The Home as an Exposure Target in Idiopathic Pulmonary Fibrosis: A Pilot Air Purification Study

Maeve G MacMurdo; Maggie Urban-Waala; Amanda Morgan; Daniel A Culver

2760 CO12 Effect of nerandomilast in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF) by baseline forced vital capacity: subgroup analyses of the FIBRONEER trials

Sonye K Danoff; Ayodeji Adegunsoye; Min Cao; Man Pyo Chung; Yasuhiko Nishioka; Markus Polke; Hui Gu; Kamila Sroka-Saidi; Susanne Stowasser; Marlies S Wijsenbeek; Divya Patel

2763 CO13 Effect of nerandomilast on risk of death in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)

Justin Oldham; Shervin Assassi; Arata Azuma; Vincent Cottin; Anna-Maria Hoffmann-Vold; Michael Kreuter; Toby M. Maher; Luca Richeldi; Claudia Valenzuela; Marlies S. Wijsenbeek; Hui Gu; Gerrit Weimann; Ivana Ritter; Susanne Stowasser; Donald F. Zoz; Fernando J. Martinez

2765 PO104 Efficacy and safety of nerandomilast in the FIBRONEER trials in patients with idiopathic pulmonary fibrosis (IPF) and progressive pulmonary fibrosis (PPF)

Justin M. Oldham; Shervin Assassi; Arata Azuma; Vincent Cottin; Anna-Maria Hoffmann-Vold; Michael Kreuter; Toby M. Maher; Luca Richeldi; Claudia Valenzuela; Marlies S. Wijsenbeek; Daniel Wachtlin; Gerrit Weimann; Ivana Ritter; Donald F. Zoz; Fernando J. Martinez

2943 PO97 Cardiac Sarcoidosis Diagnosed on Explant Pathology Following Heart Transplantation

Mohammad Umar Ahmed; Jack Tietema; Jagienka Timek; Mohamad El-Shami; Ryan Hadley; Pranav Kidambi; Renzo Loyaga-Rendon; Ryan Grayburn; Wissam Abdallah; Nagib Chalfoun; Sanjay Dandamudi

2964 PO15 Real-world neurosarcoidosis: clinical phenotypes, management, and outcomes in a single-center cohort

Martina Ceraudo; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Marcello Rattazzi; Anna Palmieri; Francesco Cinetto

2965 PO10 Clinical and neurocognitive impact of sarcoidosis: Analysis of Disease Burden and Gender Differences

Martina Ceraudo; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Marcello Rattazzi; Anna Palmieri; Francesco Cinetto

2966 PO74 Beyond weight-based dosing: high inter-individual variability and the role of Therapeutic Drug Monitoring (TDM) in the treatment of sarcoidosis with infliximab.

Martina Ceraudo; Giulia Zinni; Alessandro Dell'Edera; Riccardo Scarpa; Anna Palmieri; Marcello Rattazzi; Francesco Cinetto

2971 PO90 Predictive value of FDG uptake in thoracic lymph nodes on PET/CT during immunosuppressive therapy in cardiac sarcoidosis patients

Beverly I. de Leeuw; Harold Mathijssen; Azar Kianzad; Fatima Akdim; Karim Taha; Maarten Jan Cramer; Marcel Veltkamp; Marco C. Post

2978 PO17 Genetic variation across age groups in sarcoidosis

Johanna Leppänen; Sini Koivu; Jimi Virkkala; Katri Ruokamo-Korva; Elisa Lahtela; Inkeri A. Lokki; Marja-Liisa Lokki; Riitta Kaarteenaho; Jaakko Tyrmi; Johannes Kettunen

3060 PO8 Clinical Presentations of Familial Sarcoidosis: A Retrospective Cohort Study from Finland

Sini Koivu; Aino Puhakka; Jari Huovinen; Inna Wathén; Joakim Hulkkonen; Terttu Harju; Hannu Vähänikkilä; Hanna Jaula; Johanna Leppänen; Riitta Kaarteenaho

3151 CO17 Integrating Telomere Length Analysis into Pulmonary Fibrosis Diagnosis: Six Years of Experience

Eva M Carmona;

3169 PO26 Immune checkpoint alterations in B cells and NK cells of obese sarcoidosis patients revealed by EBUS/TBNA lymph node and peripheral blood analysis.

Agata Raniszewska-Borys; Iwona Kwiecień; Elżbieta Rutkowska; Rafał Sokołowski; Karina Jahnz-Różyk; Piotr Rzepecki

3170 PO27 PD‑1 and TIM‑3 on NK cells in sarcoidosis: stable across sex and stage, with specific associations to T-cell activation markers.

Iwona Kwiecień; Elżbieta Rutkowska; Rafał Sokołowski; Joanna Bednarek; Karina Jahnz-Różyk; Piotr Rzepecki; Agata Raniszewska

3190 PO120 Infection Burden in Sarcoidosis: Insights from a Single-Center Cohort

Claudia Tejera Quesada; Joseph Barney; Drew Robinson

3193 CO3 Diagnostic Delay and Clinical Worsening in Cardiac Sarcoidosis

A.L.M. Bakker; H. Mathijssen; J.C. Grutters; M. Veltkamp; F.Akdim; B. de Leeuw; M.C.Post

3199 PO58 Pulmonary Involvement in Systemic Diseases: Clinical Phenotypes, Radiologic Patterns, and Long-Term Functional Outcomes in a Single-Center Cohort

Dina Rnjak; Marija Šimić; Dina Mihelčić Korte; Tea Vukić Bilić; Mirta Đuzel; Matej Šapina; Marko Banić; Ana Hećimović

3201 PO85 Scar Burden in Cardiac Sarcoidosis Presenting With Malignant Ventricular Arrhythmias

Jenna Davison; Selene Rubino; Emma Johns; Andrew Rosenbaum; Courtney Arment; Konstantinos Siontis

3206 PO2 Epidemiology of Sarcoidosis in the United States: Prevalence, Incidence, and Comorbidity Burden

Yanni Fan; Haikun Bao; Catherine Allende; Alexandra Z. Sosinsky; Ann Chauffe; Madhu Kanakapura; Prethibha George; Elizabeth Volkmann; Divya Patel

3207 PO80 Risk of Pulmonary Progression and Mortality in US Patients with Sarcoidosis: A 2017–2023 Cohort Study

Yanni Fan; Haikun Bao; Catherine Allende; Alexandra Z. Sosinksy; Ann Chauffe; Madhu Kanakapura; Prethibha George; Elizabeth Volkmann; Divya Patel

3212 CO6 Antibiotic Therapy for the Cutibacterium acnes–associated phenotype in sarcoidosis: a randomized controlled trial

Montse Janssen Bonas; R. Kraaijvanger; C.A. Ambarus; R.G.M. Keijsers; A.F. van den Hoven; J.C. Grutters; M. Veltkamp

3213 PO33 Prevalence of granulomatous inflammation in the lungs in subjects with intrathoracic lymphadenopathy due to sarcoidosis and tuberculosis: Is there a difference?

Sahajal Dhooria; Kuruswamy Thurai Prasad; Ritesh Agarwal; Nalini Gupta; Amanjit Bal; Ashutosh Nath Aggarwal

3214 CO2 Financial strain, not income, is associated with worse clinical outcomes in sarcoidosis

Cierra Poole BS MS; Joyce Lee ScB; Thomas Pulliam MD PhD; Kristen R. Mathias MD MHS; Edward S. Chen MD; Nancy W. Lin MD; Stephen C. Mathai MD MHS; Nisha A. Gilotra MD; Barney Stern MD; Carlos Pardo MD PhD; Kevin Psoter PhD; Michelle Eakin PhD; Michelle Sharp MD MHS

3215 CO16 Impact of underlying genetic cause on clinical characteristics and survival in familial pulmonary fibrosis

Joanne J. van der Vis; Aernoud A. van Batenburg; Jan C. Grutters; Coline H.M. van Moorsel

3216 PO34 Omega-3 Intake is associated with Improved Clinical Outcomes in Sarcoidosis

Sara Luby DO MHSA; Cierra Poole BS MS; Kristen R. Mathias MD MHS; Edward S. Chen MD; Nancy W. Lin MD; Stephen C. Mathai MD MHS; Nisha A. Gilotra MD; Barney Stern MD; Carlos Pardo MD PhD; Michelle Eakin PhD; Jana Ponce PhD RD LMNT; Michelle Sharp MD MHS

3217 PO21 Building a sarcoidosis biomarker roadmap: finding alignment and building consensus at the Foundation for Sarcoidosis Research’s 2025 Biomarker Summit

Elise Hoover; Matthew Baker; Maneesh Bhargava; David Birnie; Ethan Fechter-Leggett; Tim Legenzoff; Joshua Fessel; Mahwash Kassi; Lisa Maier; Mary McGowan; Courtney Montgomery; Mohamed Seedahmed; Chetan Shenoy; Peter H.S. Sporn; Greer Waldrop; Arthur Yee; Tricha Shivas; Elliott Crouser

3218 PO25 Plasma Nuclear Cell-Free Nuclear DNA as a Biomarker in Sarcoidosis: A Multicenter Pilot Study

Sarbjot Grewal; Mary Richert; Samantha Shaffer; Hyesik Kong; Temesgen Andargie; Moon J Jang; Ed Chen; Michelle Sharp; Steven Holland; Shambu Aryal; Nabeel Hamzeh; Sean Agbor-Enoh

3219 PO14 Diagnostic and Healthcare Impact of Neurosarcoidosis: Insights from a Decade of Hospital Admission Data

Daniel Kurz; Michael Lonigro

3222 CO9 Efficacy and Safety of Brepocitinib in Patients with Cutaneous Sarcoidosis: Results from a Randomized, Double-Blind, Multicenter, Placebo-Controlled, Phase II (BEACON) Trial

Misha Rosenbach; Bridget Shields; Margaret Coates; Ogugua Ndili Obi; Anne L. Marano; Aaron Mangold; Oluwakemi Onajin; Anna Haemel; David Fivenson; Daniel A. Culver; Marc A. Judson; Claire Hannah; Craig Smuda; Samantha Polly; Rashmi Unwala; Logan Harper; Manuel Ribeiro Neto; Paras Vakharia; Cuong Nguyen; Galen Foulke; Matthew Helm; Sylvia Hsu; Rohit Gupta; Donna A. Culton; Robert Pariser; Jordan Talia; Katharina S. Shaw; Brendan Johnson; Lauren Graham; Joseph Barney; Sotonye Imadojemu; Avrom S. Caplan; William Damsky

3223 PO53 Infliximab-induced lupus in a patient with probable neurosarcoidosis

Jennifer Wiseman, MD; Craig Smuda, MD PhD; Daniel Kurz, MD

3224 PO108 Real-World Use of Tyvaso DPI in Patients with PH-ILD using de-identified US Electronic Health Records

Abubakr Bajwa; Kyle Davis; Kellie Morland; Benjamin Wu; Tejaswini Kulkarni

3225 PO121 A randomized controlled trial comparing the diagnostic yield of standard flexible bronchoscopy versus ultrathin bronchoscopy for bronchial mucosal biopsy in sarcoidosis

Sahajal Dhooria; Swagatha Jose; Amanjit Bal; Ritesh Agarwal

3228 PO99 VOC Breath Signatures with Diagnostic, Subtype Stratification, and Prognostic potential in Interstitial Lung Diseases

Eliza Tsitoura; Eirini Vasarmidi; Ioanna Argyriou; Matthew Kerr; Liam Grimmett; Jessica Herbert; Owen Birch; Tilly Woodland; Huw Davies; Athina Trachalaki; Marilena Lourou; Lutz Wollin; Katerina M. Antoniou

3229 PO100 The role of electronic nose (e-nose) technology in ILD diagnosis and BAL cell discrimination

Eirini Vasarmidi; Athina Trachalaki; Ioanna Argyriou; Rianne de Vries; Nikoleta Bizymi; Marilena Lourou; Konstantina Symvoulaki; Christian Hesslinger; Daniel Peter; Lutz Wollin; Eliza Tsitoura; Katerina M. Antoniou

3230 CO5 Regulatory T cell-specific CTLA-4 haploinsufficiency enhances T cell activation but does not enhance trehalose dimycolate-induced granuloma formation

Lieke de Jong; Jelle Miedema; Ingrid Bergen; Jennifer van Hulst; Rudi Hendriks; Odilia Corneth

3231 PO4 Airway exposure to micro- and nanoplastics induces macrophage activation and sarcoidosis-like granulomatous inflammation in mice

Lieke de Jong; Vicky Bogaard; Ingrid Bergen; Barbro Melgert; Elena Höppener; Ingeborg Kooter; Agnes Boots; Rudi Hendriks; Odilia Corneth; Jelle Miedema

3234 PO6 Sarcoidosis and Malignancy: A Single-Center Cohort Study of Temporal Relationships

Yub Raj Sedhai; Kathryn Hobbs; Christopher A Thomas; Christopher.King@inova.org; Oksana A Shlobin; Jared D Wilkinson; Junad M Chowdhury; Alan S Nyquist; Anju L Singhal; Zein Kattih; Steven D Nathan; Shambhu Aryal

3236 PO76 Methotrexate polyglutamates concentrations in patients with sarcoidosis treated with methotrexate monotherapy

Janssen Bonas, M; Sundaresan J.; Kahlmann V.; Wijsenbeek M.S.; Grutters, J.C.; de Rotte, M; Veltkamp, M

3241 PO16 Looking at the Both Sides of the Coin: A Pooled Analysis of Case Reports with Possible Silicosarcoidosis

Grgur Salai; Jasna Tekavec-Trkanjec; Luka Manojlović; Nevenka Piskač Živković

3242 PO36 Bronchial and peritoneal sarcoidosis in a 30 y/o asymptomatic woman: Case report

Oskar Okuniewski; Szymon Wojtylak; Grzegorz Romanowicz; Monika Skotarczak; Anna Dubaniewicz

3243 PO88 Artificial intelligence - enhanced EKG predicts presence of cardiac sarcoidosis with a high sensitivity

Emma Johns; Selene Rubino; Jenna Davison; Andrew Rosenbaum; Konstantinos Siontis; Courtney Arment

3245 PO30 Serum KL-6 levels in sarcoidosis and hypersensitivity pneumonitis: a prospective comparative study

Sahajal Dhooria; Shivani Pundeer; Mandeep Sadhra; Amanjit Bal

3246 PO62 Post-COVID ILD or Fibrotic HP? A Diagnostic Dilemma

Sevcan Yirci; Aykut Çilli

3250 PO98 ASYMPTOMATIC HEART AND OCULAR INVOLVEMENT IN MULTIORGAN SARCOIDOSIS IN 34-YEAR-OLD PATIENT

Dubaniewicz Anna; Żegleń Sławomir; Oskar Okuniewski; Jankowska Hanna; Panasik Agnieszka; Skotarczak Monika

3251 PO37 Happy Ending Story: A Case of Sarcoidosis

Feride Marim; Zeynep Yaren Yilmaz Tan; Umran Erbay; Sertas Erarslan; Mehmet Korkmaz

3253 PO38 Tuberculosis, malignancy or Sarcoidosis? A diagnostic puzzle in an HIV Patient

Carlos Mendes Araújo; Jorge Soares; Miguel Lopes

3254 PO9 Characteristics of comorbid sarcoidosis and inflammatory bowel disease in a sample of US Black women

Virginia Cafferky; Adjoa Anyane-Yeboa; Cordelia W. Russell; Hamed Khalili; Yvette C. Cozier

3255 PO109 Pulmonary Hypertension in Systemic Sclerosis: Group 1 or Group 3? A Therapeutic Challenge

Gulfer Okumus; Gokhan Altan; Zuleyha Bıngol; Derya Baykız; Murat İnanc

3256 PO31 Sarcoidosis phenotypes identified by [18]FDG PET/CT. A proof of concept study.

Małgorzata Kobylecka PhD MD; Anna Goljan-Geremek, PhD MD; Agnieszka Kołodzińska,PhD MD dr hab. n. med.,; Renata Główczyńska PhD MD; Elżbieta Puścińska PhD,MD; Konrad Giełdowski MD; Michał Kocemba MD; Krzysztof Bieńkowski MD; Joanna Żuchowska MD; Sonia Borodzicz-Jażdzyk PhD,MD; Katarzyna Romanowska-Próchnicka PhD,MD; Patrycja Nejman-Gryz,PhD,MD; Marta Maskey-Warzęchowska, PhD,MD; Lena Kalinowska; Rafał Krenke PhD,MD

3258 PO117 A Single Disease, Multiple Patterns: The Spectrum of Pulmonary Function Tests in Sarcoidosis

Züleyha Bingöl; Gökhan Altan; Sama Hasanova; Esen Kıyan; Gülfer Okumuş

3259 PO11 Decreasing quality of life associated with increased organ involvement in sarcoidosis: learnings from the Foundation for Sarcoidosis Research (FSR) Patient Registry

Ethan Fechter-Leggett; Elliott Crouser; Logan Harper; Mary McGowan; Leslie Serchuck; Tricha Shivas; Elise Hoover

3261 PO39 Sarcoidosis Mimicking Malignancy: A Diagnostic Challenge

Inês de Brito Gonçalves; Carla Margarida Carvalho; Raquel Pereira; Eva Dias Padrão

3262 PO40 Sarcoid-like reaction in mediastinal lymph nodes to lung cancer in a 67-year old woman

Dubaniewicz Anna; Żegleń Sławomir; Oskar Okuniewski; Skotarczak Monika; Szymon Wojtylak; Grzegorz Romanowicz

3263 PO69 The prednisone-free regimens exploratory (PREDFREE) study - A real-world analysis of corticosteroid-tapering sarcoidosis treatment regimens with complete corticosteroid withdrawal

W. Ennis James; Ogugua Ndili Obi; Manuel Ribeiro Neto; Nadera Sweiss; Kerry Hena; Dan Culver; Recai Yucel; Paul Feustel; Sai Anoosh Parimi; Derlis Fleitas Sosa; Sanya Chandna; Supritha Prasad; Nathaniel Nelson; Shravya Dharambhat; Joseph Mazur; Sooyeon Kwon; Marc Judson

3267 PO78 Perceived Medication Toxicity and Health-Related Quality of Life in Pulmonary Sarcoidosis

Kristen R. Mathias, MD; Cierra Poole BS, MS; Chatuthanai Savigamin, MD; Nancy W. Lin, MD; Edward S. Chen, MD; Michelle Sharp, MD, MHS

3268 PO113 SupportSarc: Protocol for A Randomized Controlled Trial of Virtual Mindfulness-Based Stress Reduction for Sarcoidosis-Associated Fatigue

Logan J Harper MD, MS; Angie Corrigan; Amanda J Shallcross ND, MPH; Xiaofeng Wang PhD; Donita Al-Amin; Dena Aruta BS, MT (ASCP); Kathleen Pantea LPN; Johnie Reed DBA; Marc Judson MD; Daniel A Culver DO

3269 CO4 Bronchoalveolar Lavage Protein Panel to Detect Beryllium Sensitization and Chronic Beryllium Disease

Maneesh Bhargava; Brian Vestal; Danielle O Weise; Timothy J Griffin; Pratik D Jagtap; Joshua Macaluso; L Ealine Epperson; Margaret Mroz; Lisa A Maier; Li Li

3270 PO12 Stress and Self-Efficacy as Key Drivers of Symptoms in Sarcoidosis — A Cross-Sectional Survey Study

Logan J Harper MD, MS; Maeve MacMurdo MBChB, MPH; Elise Hoover MPH; Xiaofeng Wang PhD; Manuel Lessa Ribeiro Neto MD; J. Daryl Thornton MD, MPH; Daniel A Culver DO

3272 PO28 Characterizing the Phosphorylation Landscape to Understanding Altered Kinase Signaling in Pulmonary Sarcoidosis

Bhargob Kakoty; Danielle O Weise; Li Li; Timothy J Griffin; Pratik D Jagtap; Subina Mehta; Justin M Drake; Megan L Ludwig; Briana Q Barkes; Eric F Lock; Lisa A Maier; Maneesh Bhargava

3273 PO75 Long-term infliximab therapy in refractory pulmonary and extra-pulmonary sarcoidosis provides sustained clinical benefit

Sinead O'Bryant MD; Joseph Barney MD; Ishan Lalani MD

3276 PO55 Diagnostic Journey and Care Pathways in Progressive Fibrosing ILDs in Portugal: interim results from a national registry

Cláudia Guerreiro ; Alexandra Borba; Ana Loureiro; Ana Verónica Cardoso; Carla António; Catarina Pereira; David Barros Coelho; Daniela Neves; Lígia Fernandes; Marisa Anciães; Miguel Lopes; Nelson Marçal; Pedro Gonçalo Ferreira; Rita Pinto Basto; Rita Simões; Susana Clemente; Sofia Neves; António Morais; Vanda Areias

3278 PO94 Steroid stewardship in cardiac sarcoidosis: bone health monitoring and prevention in a tertiary cardiac sarcoid cohort

Dhruv Thakur; Juan Carlos Quijano-Campos; Fiona Kearl; Marina Zaromytidou; Gavin Thomas; Neha Sekhri; Richard Toshner

3281 PO93 Angiotensin receptor-neprilysin inhibitor (Sacubitril/Valsartan) in cardiac sarcoidosis induced heart failure; real-world experience from a nurse-led clinic

Miss Hannah De la Salle; Dr Rakesh Sharma; Dr Vasileios Kouranos

3282 PO101 Myoferlin — new player in idiopathic pulmonary fibrosis pathogenesis?

Mimosa Peltokangas; Mervi Kreus; Steffen Ohlmeier; Siri Lehtonen; Henna karvonen; Elisa Lappi-Blanco; Johanna Leppänen; Riitta Kaarteenaho

3284 PO41 Not All Granulomas Are Sarcoidosis: Vertebral Tuberculosis Mimicking Disease Progression

Sofia Basílio Quaresma; Mariana Godinho; Gabriela Santos; Carlos Araújo; Inês Estalagem; Inês Oliveira; Miguel Lopes

3286 PO119 Clinical bronchial hypersensitivity in sarcoidosis - more significant than we think?

Julia Rutkowska; Patrycja Nejman-Gryz; Anna Goljan-Geremek; Elżbieta Puścińska; Małgorzata Kobylecka; Joanna Żuchowska; Patrycja Roguska; Magdalena Dąbrowska; Maria Kaczorowska-Małek; Marta Maskey-Warzęchowska; Rafał Krenke

3290 PO63 Not All Cysts Are the Same: A Single-Center Experience in Cystic Lung Diseases

Gülfer Okumuş; Gökhan Altan; Ayşe Nur Ertuğrul; Esen Kıyan; Züleyha Bingöl

3291 PO1 Sex-based phenotypic differences and outcomes in sarcoidosis: data from the SARCO-I Spanish multicentre registry

Juan Jose Zapata Huizi; Joel Francesqui; Daniel Ramos; Elena Bollo de Miguel; Ana Villar Gomez; Pablo Flórez Solarana; Eva Balcells Vilarnau; Gema Castaño; Erwin Pinillos Robles; Raul Godoy Mayoral; Belén López Muñiz; María José Soler-Sampere; Diego Castillo; Albert Rafecas-Codern; Pablo Mariscal Aguilar; Luis Gomez Carrera; Gema Bonilla; Paloma Millan Pilli; Karina Portillo; Fernanda Hernández-González; Jacobo Sellares

3292 PO32 Changes in T cell cytokine profiles at baseline associate with treatment response in the PREDMETH study

Vicky C.S. Bogaard; Willemijn L. Driesse; Marlies S. Wijsenbeek; Vivienne Kahlmann; Catharina C. Moor; Montse Janssen Bonás; Marcel Veltkamp; Rudi W. Hendriks; Jelle R. Miedema; Odilia B.J. Corneth

3293 PO23 Clinical Application of Serum Lymphopenia in Sarcoidosis Evaluation: Can It Serve as a Marker of Disease Extent and Disability?

Anna Goljan Geremek; Patrycja Nejman Gryz; Malgorzata Kobylecka; Elzbieta Puscinska; Agnieszka Kolodzinska; Renata Glowczynska; Sonia Borodzicz Jazdzyk; Joanna Zuchowska; Katarzyna Romanowska Prochnicka; Marta Maskey Warzechowska; Julia Rutkowska; Lena Kalinowska; Jolanta Kunikowska; Rafal Krenke

3294 CO11 Decline in Forced Vital Capacity and Survival in fibrotic Hypersensitivity Pneumonitis; Time to revisit the definition of Progressive Pulmonary Fibrosis guidelines?

E. Lynn; J. Tadjkarimi; A. Trachalaki; E. Renzoni; S. Bax; R. Hewitt; G. Jenkin; P. George; C. Stock; A. Wells

3295 PO106 Nintedanib Affects Adaptive Immunity in Idiopathic Pulmonary Fibrosis

Bryn Bogaard; Stefan Neys; Willemijn Driesse; Jennifer Schipper-van Hulst; Rudi Hendriks; Thomas Koudstaal; Odilia Corneth

3297 PO81 FVC Decline in Advanced Pulmonary Sarcoidosis is Associated with Reduced Survival: Results of the ReAS Study

Ashley Cattran; Ogugua N. Obi; Robert P. Baughman; Marc Judson; Surinder Birring; Helmi Van Hirtum; Marcel Veltkamp; W. Ennis James; Lisa Maier; Violetta Vucinic; Eva Carmona; Mehdi Mirsaedi; Vasileios Kouranos; Athol U. Wells; Elyse E. Lower

3301 CO14 Pulmonary Hypertension Screening in Interstitial Lung Disease: Interim Comparison of Clinician Suspicion vs Right Heart Catheterization in the PHINDER Study

Claire Thrasher; Sandeep Sahay; Tejaswini Kulkarni; Oksana Shlobin; Abhijit Raval; David Kiely; Maral DerSarkissian; Matthew Hunsucker; David Zisman; Meredith Broderick; Dasom Lee; Kevin Maher; Mary Beth Scholand

3304 PO43 Granulomatous Lung Disease Mimicking Sarcoidosis in a Patient with Silica Exposure

Ana Castelo Grande; Ana Verónica Cardoso

3307 PO107 Interstitial Lung Disease with and without Mean Pulmonary Artery Pressure >20 mmHg: Interim Results from the PHINDER Study

Claire Thrasher; Bradford Bemiss; Oksana Shlobin; David Zisman; Karla Cruz Morel; Maral DerSarkissian; Tejaswini Kulkarni; Meredith Broderick; Dasom Lee; Kevin Maher; Mary Beth Scholand; David Kiely

3308 PO73 Targeting the JAK-STAT pathway in Progressive Fibrotic Pulmonary Sarcoidosis: Functional and Physiologic Improvement with Tofacitinib in a 20-Patient Case Series

Arda Kiani; Atefeh Abedini; Pegah Soltani; Akram Ghanavati; Kimia Taghavi

3309 CO8 One-year follow up of the PREDMETH trial; a randomized controlled trial comparing prednisone with methotrexate in pulmonary sarcoidosis

Friso de Weert; Marlies Wijsenbeek; Montse Janssen Bonás; Jan C. Grutters; Rémy L.M. Mostard; Henricus N.A.J. van Rijswijk; Jan van der Maten; Kelly M.C. van Doorn; Linda A.A. Moonen; Maria J. Overbeek; Bart Koopman; Marco Grootenboers; Esther J. Nossent; Michiel Wagenaar; Henk Kramer; Eveline Schakenraad; Peter I. Bonta; Stefan Walen; Chantal Knoops; Mayka Overgaauw; Marcel Veltkamp; Catharina C. Moor; Vivienne Kahlmann

3310 PO105 Determinants of Long-Term Progression in Hypersensitivity Pneumonitis: The Role of Phenotype and Early Lung Function Change

Mirta Đuzel; Marko Banić; Dina Mihelčić Korte; Dina Rnjak; Ana Hećimović

3311 PO5 Occupational and Environmental Associations with Baseline Organ Involvement in a Real-World Sarcoidosis Cohort

Mark B. Mallozzi, MD, MPH; Josh J. Solomon, MD; Briana Q. Barkes; Margaret M. Mroz; Mary E. Richert; Clara I. Restrepo; Lisa A. Maier

3313 CO7 Impact of Early Diagnosis and Early Initiation of Infliximab on Long-Term Disability in Neurosarcoidosis

Brandon P. Moss, MD; Scott Husak; Manuel L. Ribeiro Neto, MD; Daniel A. Culver, DO; Julia O'Mahony, PhD

3315 PO13 Ten Clinical Sites Across the United States to Collaborate to Collect Data on Patients with Multisystem Sarcoidosis

Elise Hoover; Mridu Gulati; Matthew Baker; Briana Barkes; Paula Barreras; William Damsky; Ethan Fechter-Leggett; Elizabeth Frame; Logan Harper; Taylor Harwood; Ravi Karra; Timothy Legenzoff; Craig Lipset; Mary McGowan; Courtney Montgomery; Brandon Moss; Ogugua Obi; Misha Rosenbach; Farooq H. Sheikh; Peter H.S. Sporn; Leslie Serchuck; Tricha Shivas; Lisa Maier

3316 PO116 Association of respiratory oscillometry with health-related quality of life in sarcoidosis

Robert Wharton; Cierra Poole; Kevin Psoter; Kristen Mathias; Edward Chen; Nancy Lin; Stephen Mathai; Michelle Eakin; Michelle Sharp

3321 PO115 Delphi CT Phenotypes of Sarcoidosis: Reliability, and Lung Function Associations

Lisa A Maier, MD, MSPH; Wren L Lippitt, PhD; Giovanni Mancò, MD; Samuel Friedlander, MD; Shu-Yi Liao, MD, MPD, ScD; Briana Q Barkes, MPH; Margaret M Mroz, MS; Tasha E Fingerlin, PhD; Nichole E Carlson, PhD; David A Lynch, MB, BCh

3325 PO20 Epigenetic and Transcriptomic Profiling of Peripheral Blood Mononuclear Cells in Fibrotic and Non-Fibrotic Pulmonary Sarcoidosis

Lisa A. Maier, MD, MSPH; Brian Vestal, PhD; Camille Moore, PhD; Cheyret Wood MS; Jonathan Cardwell, MS; Joshua Macaluso; Margaret M. Mroz, MS; Clara I. Restrepo, MD; Ivana Yang, PhD; Li Li, MD, PhD

3326 PO51 Fibrotic pulmonary sarcoidosis with persistent inflammatory activity: corticosteroid toxicity and barriers to treatment escalation

Pedro Marinho Manso; Ana Castelo Grande; Nuno de Barros Ferreira; Ivone Gonçalves

3327 PO59 Impact of Rheumatologist Involvement on Diagnostic and Treatment Optimization in Interstitial Lung Disease

Tiago Antunes de Sá; Teresa Machado; Luís Lázaro; Eduarda Tinoco; Cristina Alves; Carla Nogueira; Patrícia Pinto; Ana Ribeiro; Célia Sousa; Inês Marques; Sérgio Campainha; Sofia Neves

3328 CO10 Integrating DLCO with FVC in Fibrotic Hypersensitivity Pneumonitis: How do we better model mortality in Progressive Pulmonary Fibrosis ?

James Tadjkarimi; Evelyn Lynn; Punchalee Kaenmuang; Athina Trachalaki; Vasileios Kouranos; Peter George; Simon Bax; Maria Kokosi; Carmel Stock; Richard Hewitt; Elizabeth Renzoni; Athol Wells

3339 PO111 Prevalence and Characteristics of Sarcoidosis-associated Myositis, A Single Center Cohort Experience

Timothy Kennell Jr; Joseph Barney

3340 PO45 Immunotherapy-induced sarcoidosis: A case series

Margarida Almeida; Francisco Mano; Inês Coutinho; Pedro Ferreira; Tiago Alfaro; Margarida Afonso

3344 PO46 Post-COVID-19 Sarcoidosis: An Emerging Clinical Phenotype and Diagnostic Challenge

Gabriela Fonseca Santos; Matilde Ferreira de Almeida; João Cruz; Miguel Silva Lopes; Jorge Humberto Soares

3351 PO19 Peripheral blood leukocyte telomere length, fatigue, and pulmonary fibrosis in sarcoidosis: a cross-sectional study.

Karol Bączek; Daria Domańska-Senderowska; Monika Migdalska-Sęk; Anna Litwin; Łukasz Izbiński; Ewa Brzeziańska-Lasota; Wojciech Jerzy Piotrowski

3352 PO67 A Spectrum of Lymphoproliferation: From LIP to MALT Lymphoma in Sjögren Syndrome

Pedro Vicente de Almeida; Sofia Martins Castro; Maria Aurora Mendes; Eduardo Dourado; Dino Andrade Luís; Margarida Ferreira; João Cravo

3353 PO72 Evaluation of the impact of methotrexate on patients with chronic sarcoidosis

Alexander A. Vizel; Robert P. Baughman; Sergey N. Avdeev; Irina Yu. Vizel; Gulnaz R. Shakirova

3357 PO29 IDO1 as an Immunometabolic Checkpoint of Granuloma Formation in Sarcoidosis

Marcela Oliveira; Diana Santos-Ribeiro; Relber A. Gonçales; Cátia Rodrigues; Francisca Costa; Oksana Sokhatska; Chiara Suvieri; Luís Delgado; António Morais; Natalia V Rivera; Claudia Volpi; Hélder Novais Bastos; Cristina Cunha; Agostinho Carvalho

3358 CO1 Clinical and phenotypic characterisation of pulmonary sarcoidosis in Spain: a multicentre cluster analysis

Joel Francesqui; Elena Bollo; Ana Villar; Pablo Flórez; Eva Balcells; Gema Castaño; Erwin Javier Pinillos-Robles; Raúl Godoy-Mayoral; Belén López-Muñíz; María José Soler-Sampere; Diego Castillo; Albert Rafecas-Codern; Pablo Mariscal-Aguilar; Paloma Millan-Billi; Karina Portillo; Fernanda Hernandez-Gonzalez; Jacobo Sellares

3361 PO89 Enhanced Myocardial Suppression on ¹⁸F-FDG PET/CT in Suspected Cardiac Sarcoidosis with an 18-Hour Fasting Protocol

HY Santema; D Vriens; FAJ Esser; HMJ Siebelink; JL Stöger; JJ Goeman; JRG Torremans; MM Tjong Joe Wai; P Dibbets-Schneider; MJJ Geelhoed; FL Stevens; MK Ninaber; LF de Geus-Oei

3364 PO54 Progressive Fibrosing ILD in Portugal: Interim Epidemiological and Clinical Results from a National Multicenter Registry

Sofia Neves; Alexandra Borba; Ana Loureiro; Ana Verónica Cardoso; Carla António; Cláudia Guerreiro ; Catarina Pereira; David Barros Coelho; Daniela Neves; Lígia Fernandes; Marisa Anciães; Miguel Lopes; Nelson Marçal; Pedro Gonçalo Ferreira; Rita Pinto Basto; Rita Simões; Susana Clemente; António Morais

3366 PO52 Anti-Tumor Necrosis Factor Therapy Induced Neurosarcoid: A Curiosity or a Cautionary Tale?

Amanda Abuaf;

3370 PO79 Clinical Profile and Prognostic Determinants of Pulmonary Sarcoidosis: A Real-World Experience from a Regional Referral Center

Ana Castelo Grande; Filipa Lemos e Aguiar; Francisco Cadarso; Ivone Gonçalves; Ana Verónica Cardoso

3371 CO15 Pulmonary Hypertension in Pulmonary Langerhans Cell Histiocytosis: Insights from 71 Patients

Ramdeep Bajwa; Amira Benattia; Carmel Stock; Manuel Lopez Meseguer; Effrosyni Manali; Berta Saez-Gimenez; Cormac McCarthy; Donal O'Malley; Frantzeska Frantzeskaki; Ioannis Tsagkaris; Elzbieta Radzikowska; Claudia Ravaglia; Roberto Cassandro; Davide Elia; Spyridon Papiris; Venerino Poletti; Sergio Harari; Laura Price; Abdellatif Tazi; Athol Wells; Maria Kokosi

3372 CO18 Clinical Significance of Serum KL-6 in Fibrotic Interstitial Lung Diseases

Maria Kokosi; Eirini Vasarmidi; Athina Trachalaki; Carmel Stock; Vasileios Kouranos; Felix Chua; Simon Bax; Richard Hewitt; Elisabetta Renzoni; Nikolaos Tzanakis; Peter George; Athol Wells; Katerina Antoniou

3373 PO84 Sex Disparities in ECG Screening at Initial Sarcoidosis Diagnosis: A Retrospective Study of 7,468 Adults

Saloni Sachar DO, MS; Logan J Harper MD, MS; Daniel A Culver DO; Manuel L. Ribeiro Neto MD, PhD

3374 PO56 Characterization of a Multicenter Portuguese Cohort with Unclassifiable Interstitial Lung Disease

Rita de Vasconcelos Pereira; Ana Rita Ribeiro; Andreia Daniel; Carla Carvalho; Pedro Vicente de Almeida; Helena Carvalho; Nuno Ferreira; Luís Silva; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais

3375 PO57 The role of biopsy in the diagnosis and management of Unclassifiable Interstitial Lung Disease

Ana Rita Ribeiro; Rita de Vasconcelos Pereira; Andreia Daniel; Carla Carvalho; Pedro Vicente de Almeida; Helena Carvalho; Nuno Ferreira; Luís Silva; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais

3376 PO102 The Vagus Nerve conducts viable translocation of gut flora to the lungs that impacts interstitial lung disease severity in mice

Wonder Drake; Amit Kuman; Pooja Keerthipati; NOrberto Gonzalez-Juarbe

3377 PO95 Hemodynamic and Histopathologic Features of Pulmonary Hypertension in Explants from Advanced Pulmonary Sarcoidosis

Jin Sun Kim; Colin Dunn; Amandeep Aneja; Rohit Gupta

3378 PO65 Alveolar macrophage pneumonia: impact of smoking cessation and corticosteroid therapy

Andreia Daniel Simões; Ana Rita Ribeiro; Pedro Vicente de Almeida; Carla Carvalho; Helena Carvalho; Luís Silva; Nuno Ferreira; Rita de Vasconcelos Pereira; André Alexandre; David Coelho; Hélder Novais Bastos; Patrícia Mota; Natália Melo; Susana Guimarães; Conceição Souto Moura; André Carvalho; António Morais

3379 PO103 Telomere-Related Gene Variants in Fibrotic Hypersensitivity Pneumonitis and Idiopathic Pulmonary Fibrosis

Inês Luís; Rita F. Santos; Nuno Osório; Diana Gomes; Andreia Coelho; Mariana Resende; David Coelho; Janete Santos; Oksana Sokhatska; Marília Beltrão; Natália Melo; Patrícia Mota; André Terras; André Carvalho; Susana Guimarães; Conceição Souto Moura; Ana Grangeia; António Morais; Hélder Novais Bastos

3380 PO114 Fatigue Assessment in Patients with Sarcoidosis Using the Fatigue Assessment Scale

Joana Soares Queirós; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira

3381 PO22 Inflammatory Markers and Disease Severity in Sarcoidosis

Joana Soares Queirós; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira

3382 PO47 Lung Adenocarcinoma Mimicking Sarcoidosis: A Case Report and Diagnostic Challenge

Joana Soares Queirós; Cláudia Sousa; Pedro Mendes; Rudi Fernandes; Samuel Pereira; Vítor Teixeira

3383 PO60 Characterization of household mould exposure in patients with fibrotic ILDs

Andreia Coelho; Mariana Resende; Diana Gomes; Inês Luís; João Rufo; Mónica Vieira; David Coelho; Rita F. Santos; Janete Santos; Oksana Sokhatska; Marília Beltrão; Natália Melo; Patrícia Mota; André Terras; André Carvalho; Susana Guimarães; Conceição Souto Moura; António Morais; Hélder Novais Bastos

3384 PO48 Asymptomatic Primary Cavitary Sarcoidosis: A Case of Radiological Progression Guiding Treatment Decision

Tiago Antunes de Sá; Teresa Machado; Luís Lázaro; Carina SIlva; Inês Marques; Eduarda Tinoco; Cristina Alves; Carla Nogueira; Sérgio Campainha; Sofia Neves

3385 PO96 Aortic Involvement in Sarcoidosis: An Underrecognized Manifestation Revealed by 18F-FDG PET-CT

Constança Durão; Gonçalo Moura Portugal; Joana Rodrigues Barbosa; Sara Salgado; Rita Pinto Basto

3386 PO49 Beyond the Chest CT: Sight-Threatening Neuro-Ophthalmic Sarcoidosis Emerging From an Apparent Lofgren Syndrome

Suchi Shah; Dhairya Shah; Fatima Abdulle

3388 PO50 “From Chest to Brain”: Three Clinical Presentations of Neurosarcoidosis Spectrum

João Maria Bento; Mariana Rodrigues de Oliveira; Leandra Fagundes; Juliana Barata; Eunice Magalhães; Pedro Ferreira; Maria La Salete Valente

3431 PO118 Effect of Race-Neutral (GLI Global 2022) versus Race-Based (GLI 2012) Spirometry Reference Equations on Pulmonary Function Test Interpretation in Sarcoidosis

Fortune Alabi; Lusmelys Guevara; Noah Andersen; Jica Garces; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail

3432 PO3 Race-stratified phenotype of sarcoidosis in community pulmonary practice: a 10-year, multisite experience

Fortune Alabi; Lusmelys Guevara; Noah Andersen; Jica Garces; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail

3433 PO71 Race and pharmacologic treatment patterns in patients with sarcoidosis: A 10-year, multisite community pulmonary practice experience

Fortune Alabi; Jica Garces; Noah Andersen; Lusmelys Guevara; Kenny Alvarado; Mohammad Ahmadzai; Reema Ismail

3476 PO70 Steroid-Sparing and Pulmonary Stability Across XTMAB-16 Dose Regimens in Pulmonary Sarcoidosis: Cohort-Level Findings from XTMAB-16-201 Part A

Noopur Singh; Thomas Matthews; Keith Robinson

3500 PO64 The Diagnostic Journey in Rare Interstitial Lung Diseases in Türkiye: A Multicenter TRILD Registry Study on Healthcare Levels, Referral Pathways, and Timing

Ceren Degirmenci; Nazli Cetin; Orkun Eray Terzi; Goksel Altinisik; Ozlem Ozdemir Kumbasar; Ilknur Basyigit; Sureyya Cetin Yilmaz; Burcu Baran; Asli Alkan; Kubra Gungor; Zuleyha Bingol; Gulfer Okumus; Gokhan Altan; Serhat Erol; Habibe Hezer; Serap Argun Baris; Oguz Karcioglu; Inci Gulmez; Pinar Yildiz Gulhan; Damla Serce Unat; Celalettin Korkmaz; Omer Ozbudak; Nurdan Kokturk; Talat Kilinc; Gulsah Gunluoglu; Aliye Gamze Calis; Hulya Dirol; Mehmet Parlak; Kubra Taskaraca Karabacak; Ilker Yilmam; Senay Yilmaz; Elif Yelda Niksarlioglu; Elif Yildirim; Nesrin Ocal; Oguz Uzun; Fatma Arslan; Aylin Ozgen Alpaydin; Ramazan Eren; Emine Aksoy; Ezgi Demirdogen; Sermin Borekci; Nazli Huma Teke; Derya Kocakaya; Gulru Polat; Aycan Yuksel; Ceren Ilgar Akelma; Ilgim Vardaloglu; Aysu Sinem Koc; TRILD Study Group; Eylem Sercan Ozgur

3503 PO66 Determinants of Disease Progression in Immunosuppressive Therapy–Treated Rare Cystic and Interstitial Lung Diseases: A Multicenter Real-World Study from the TRILD Registry

Ramazan Eren; Goksel Altinisik Ergur; Ozlem Ozdemir Kumbasar; Burcu Baran; Aslı Alkan; Gulsah Gunluoglu; Serap Argun Baris; Oguz Uzun; Gulfer Okumus; Zuleyha Bingol; Elif Yelda Ozgun Niksarlioglu; Hulya Dirol; Inci Gulmez; Habibe Hezer; Aylin Ozgen Alpaydin; Mehmet Parlak; Aycan Yuksel; Sureyya Cetin Yilmaz; Oguz Karcioglu; Senay Yilmaz; Pinar Yildiz Gulhan; Ilknur Basyigit; Ismail Hanta; Gokhan Altan; Ozge Oral Tapan; Omer Ozbudak; Kubra Gungor; Nurdan Kokturk; Ahmet Ursavas; Derya Kocakaya; Nurevsan Kusdogan; Talat Kilic; Fatma Arslan; Nesrin Ocal; Ilker Yılmam; Ersin Alkilinc; Meltem Agca; Ilgim Vardaloglu; Emine Arguder; Isil Uzel; Baris Demirkol; Nazli Cetin; Orkun Eray Terzi; Ceren Ilgar Akelma; Ceren Degirmenci; Aysu Sinem Koc; Serhat Erol; Eylem Sercan Ozgur; Gulru Polat

3612 PO122 Itaconate Restrains Granuloma Formation by Modulating Macrophage Activation and Transformation

Cátia Rodrigues; Relber A. Gonçales; Marcela Oliveira; Diana Santos-Ribeiro; Rita Silva-Gomes; António Morais; Hélder Novais e Bastos; Cristina Cunha; Agostinho Carvalho

3613 PO123 Evaluating efzofitimod in a subset of sarcoidosis with the restrictive phenotype

Vis Niranjan, MD; Pavithra Ramesh, MS; Sanjay Shukla, MD; Nelson Kinnersley PhD; Daniel A. Culver, DO